EDWARD O. LANPHIER II

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

SANGAMO THERAPEUTICS, INC

Filing Date Source Excerpt
2011-04-21 Edward O. Lanphier II, age 54, the founder of Sangamo BioSciences, Inc., has served as President, Chief Executive Officer and as a member of our Board of Directors since Sangamo's inception in 1995.
2012-04-25 Edward O. Lanphier II, age 55, the founder of Sangamo BioSciences, Inc., has served as our President, Chief Executive Officer and as a member of our Board of Directors since Sangamo's inception in 1995. ... Dr. Dilly and Mr. Lanphier serve on the Clinical Review Committee.
2013-04-25 Edward O. Lanphier II, age 56, the founder of Sangamo BioSciences, Inc., has served as our President, Chief Executive Officer and as a member of our Board of Directors since Sangamo's inception in 1995.
2014-03-11 Edward O. Lanphier II, age 57, the founder of Sangamo BioSciences, Inc., has served as our President, Chief Executive Officer and as a member of our Board of Directors since Sangamo's inception in 1995. Mr. Lanphier's day to day leadership and intimate knowledge of Sangamo's business and operations provide the Board with an in-depth understanding of the Company. He serves on the Clinical Review Committee.
2015-04-28 Edward O. Lanphier II, age 58, the founder of Sangamo BioSciences, Inc., has served as our President, Chief Executive Officer and as a member of our Board of Directors since Sangamo’s inception in 1995.
2016-04-25 Edward O. Lanphier II, age 59, the founder of Sangamo BioSciences, Inc., has served as our President, Chief Executive Officer and as a member of our Board of Directors since Sangamo's inception in 1995. ... Mr. Lanphier's day-to-day leadership and intimate knowledge of Sangamo's business and operations, as well as Sangamo's relationships with partners, collaborators and investors, provide the Board with an in-depth understanding of the Company. ... Mr. Lanphier serves as the Chairman of the Board effective immediately following the Annual Meeting. ... The Clinical Review Committee currently consists of three directors: Dr. Dilly, Dr. Mento and Mr. Lanphier. Dr. Dilly serves as the Chairman of this committee.

Data sourced from SEC filings. Last updated: 2026-02-03